Add to MyYahoo RSS

Patanol, Olopatadine News

News on Patanol, Olopatadine (generic) continually updated from thousands of sources around the net.

Sep 23, 2013 | JD Supra

Court Report -- September 22, 2013

Alcon Research, Ltd. et al. v. Wockhardt Ltd. et al. 1:13-cv-01452; filed September 12, 2013 in the Southern District of Indiana Infringement of U.S. Patent Nos.


Related Topix: Medicine, Conjunctivitis, Health, Biotech, NPS Pharmaceuticals, Healthcare Industry

Tue Nov 20, 2012

FDA Sends Letter to Alcon Research Regarding Sales Aid

PharmaLive is reprinting a letter the FDA posted to its website yesterday that the agency sent to Alcon Research regarding a profession sales aid for Patanase Nasal Spray.

1 comment

Related Topix: Food and Drug Administration, Medicine, Medication

Wed Sep 12, 2012

Olopatadine - Key patent, SPC, and data exclusivity expiry (7 country ...

This Pipeline Selector report covers Olopatadine Olopatadine indications: Treatment of allergic conjunctivitis Olopatadine innovator: Alcon Examples of information found in this online report include: - Includes key patent publications for 7 countries - Contains SPC protection for every EU state plus patent term extensions in other countries - Data ... (more)


Related Topix: Medicine, Medication, Conjunctivitis, Health, Marketing

Wed Aug 15, 2012

Patently Obvious

Recent Federal Circuit Nonobviousness Opinions: Alcon v. Apotex

I'm catching up with recent Federal Circuit opinions this week. First up, a trio of precedential opinions involving nonobviousness, a surprisingly hot topic.


Related Topix: Healthcare Law, Law, Medicine, Medication, Opinion, Aruba

Mon Aug 13, 2012

JD Supra

Alcon Research, Ltd. v. Apotex Inc.

Writing for the majority in Alcon Research, Ltd. v. Apotex Inc. last Wednesday, Judge Moore took issue with a position advanced by Alcon's counsel that would have essentially allowed a court to rewrite patent claims to preserve validity.


Related Topix: Medicine, Medication